Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Chemesis Internation (CADMF)
0.551 ? 0.047 (9.33%)
Volume: 64,014 @12/07/20 11:58:38 AM EST
Bid Ask Day's Range
0.55 0.565 0.4981 - 0.558
CADMF Detailed Quote
Chemesis Internation (CADMF)
0.551 ? 0.047 (9.33%)
Volume: 64,014 @12/07/20 11:58:38 AM EST
Bid Ask Day's Range
0.55 0.565 0.4981 - 0.558
CADMF Detailed Quote
Chemesis Internation (CADMF)
N/A ? N/A (N/A%)
Volume: 0 @-
Bid Ask Day's Range
- - - - -
CADMF Detailed Quote
Chemesis Internation (CADMF)
0.37425 ? 0.00425 (1.15%)
Volume: 30,688 @10/23/20 3:59:19 PM EDT
Bid Ask Day's Range
0.35 0.375 0.315 - 0.395
CADMF Detailed Quote
Chemesis Internation (CADMF)
0.5 ? -0.08 (-13.79%)
Volume: 246,983 @09/24/20 3:59:30 PM EDT
Bid Ask Day's Range
0.4499 0.63 0.497 - 0.581
CADMF Detailed Quote
Chemesis Internation (CADMF)
0.6535 ? -0.0065 (-0.98%)
Volume: 216,946 @09/04/20 3:58:51 PM EDT
Bid Ask Day's Range
0.625 0.69 0.5925 - 0.7475
CADMF Detailed Quote
Chemesis Internation (CADMF)
0.6535 ? -0.0065 (-0.98%)
Volume: 216,946 @09/04/20 3:58:51 PM EDT
Bid Ask Day's Range
0.625 0.69 0.5925 - 0.7475
CADMF Detailed Quote
Chemesis Internation (CADMF)
0.615 ? -0.019 (-3.00%)
Volume: 62,792 @08/14/20 3:44:58 PM EDT
Bid Ask Day's Range
0.615 0.695 0.59 - 0.63755
CADMF Detailed Quote
Chemesis Internation (CADMF)
0.615 ? -0.019 (-3.00%)
Volume: 62,792 @08/14/20 3:44:58 PM EDT
Bid Ask Day's Range
0.615 0.695 0.59 - 0.63755
CADMF Detailed Quote
$CADMF FUNDS
RE;
1.8 million in cash on hand at end of last quarter. Convertibles @ $1.25, warrants @ $1.98 avg. November they said they had the license under review, over $1.6 million in product ready to be sold here.
Share Structure as of 01/07/2020
Authorized shares Unlimited
Outstanding Shares 11,498,759
Market Cap 4,800,000
52-Wk Range 0.2489 - 17.20
https://www.otcmarkets.com/stock/CADMD/profile
https://chemesis.com/
https://www.facebook.com/chemesisinternational/
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=153209599
Quote:
During the year ended June 30, 2019, the Company completed two tranches of convertible debt financing for total
gross proceeds of $3,500,000. The first tranche of $2,000,000 closed on December 4, 2018 and the final tranche
of $1,500,000 closed on December 20, 2018. The convertible debentures bear interest at a rate of 8% per year and
mature two years from the closing date. The convertible debentures are unsecured and are convertible, at the
option of the holder, into common shares of the Company at a price of $1.25 per common share.
The Company has the right to repay and cancel the convertible debentures at any time prior to the maturity date
at a price equal to 105% of the principal amount of the convertible debentures then outstanding plus accrued and
unpaid interest thereon. In addition, the Company has the right to compel the conversion of the convertible
debentures in the event that the daily volume weighted average trading price of the common shares exceeds $2.50
per common share for 10 consecutive trading days.
Quote:
As of November 26, 2019, the Company’s Puerto Rican manufacturing and cultivation licenses are currently
subject to administrative review by the Department of Health in Puerto Rico and until the review has been
completed, the Company is not permitted to carry out licensed activities aside from preserving its inventory. The
Company has considered this in the preparation of these consolidated financial statements.
$CADMF Chemesis Internation (CADMF)
0.614 ? -0.02 (-3.15%)
Volume: 37,604 @08/14/20 12:28:22 PM EDT
Bid Ask Day's Range
0.6025 0.615 0.59 - 0.63755
CADMF Detailed Quote
$CADMF THANK YOU
Chemesis International Inc. Signs Exclusive Offtake Agreement with HempRico
Press Release | 09/26/2019
VANCOUVER, British Columbia, Sept. 26, 2019 (GLOBE NEWSWIRE) -- Chemesis International Inc. (CSE: CSI) (OTC: CADMF) (FRA: CWAA) (the “Company” or “Chemesis”), is proud to announce its subsidiary, Natural Ventures, has signed an exclusive offtake agreement with HempRico LLC, (“HempRico”). HempRico has received a hemp cultivation license in Puerto Rico, and will begin planting an initial high-potency hemp crop in the coming weeks.
Natural Ventures is continuing to work with cultivators in Puerto Rico, by providing cultivators with direct access to high-quality manufacturing services. With the agreement with HempRico, the Company will manufacture high-potency CBD products for the medical market through finished goods such as tinctures, patches, edibles, and other high-CBD hemp-derived products. These products will be manufactured to a high standard to ensure compliance for distribution to international markets.
HempRico’s cultivation area is located in Cayey, a mountainous municipality that has a unique micro-climate for growing. The Company expects the elevation will provide consistently high-CBD crops that will be used to supply the medical market.
“Through this exclusive offtake agreement, Natural Ventures receives additional biomass and thus ensures our facilities receive a consistent supply of raw material from various sources,” said Chief Executive Officer, Edgar Montero. “Bolstering our production capability is a key element to ensure the Company is able to process the increasing amount of high-CBD crops. As Puerto Rico issues more licenses, Natural Ventures will work with cultivators and provide extraction and finished good manufacturing.”
On Behalf of The Board of Directors
Edgar Montero
CEO and Director
About Chemesis International Inc.
Chemesis International Inc. is a vertically integrated U.S. Multi-State operator with International operations in Puerto Rico and Colombia.
The Company focuses on prudent capital allocation to ensure it maintains a first mover advantage as it enters new markets and is committed to differentiate itself by deploying resources in markets with major opportunities. The Company operates a portfolio of brands that cater to a wide community of cannabis consumers, with focus on quality and consistency.
Chemesis has facilities in both Puerto Rico and California and is in the process of constructing a GMP certified facility in Colombia. Chemesis’ Puerto Rico operations are licensed to operate 100,000 ft2 of cultivation, and 35,000 ft2 of manufacturing floor space. The Company is positioned to win additional licenses in highly competitive merit-based US states and will expand its footprint to ensure it maintains a first mover advantage.
Investor Relations:
ir@chemesis.com
1 (604) 398-3378
Social Media:
Chemesis.facebook
Chemesis.twitter
Chemesis.instagram
DesertZen.instagram
GreenSpiritRX
$CADMF REVERSE SPLIT[one for 10 reverse split:]
CADMF: effective Dec. 20 a one for 10 reverse split:
https://otce.finra.org/otce/dailyList?viewType=Symbol%2FName%20Changes
Up .22 today, nice. That .95 ask will get hit on the open if I have to do it myself. I see a dollar tomorrow, go Chemesis!
1.8 million in cash on hand at end of last quarter. Convertibles @ $1.25, warrants @ $1.98 avg. November they said they had the license under review, over $1.6 million in product ready to be sold here.
Share Structure as of 01/07/2020
Authorized shares Unlimited
Outstanding Shares 11,498,759
Market Cap 4,800,000
52-Wk Range 0.2489 - 17.20
https://www.otcmarkets.com/stock/CADMD/profile
https://chemesis.com/
https://www.facebook.com/chemesisinternational/
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=153209599
CADMF: effective Dec. 20 a one for 10 reverse split:
https://otce.finra.org/otce/dailyList?viewType=Symbol%2FName%20Changes
Okay ,, What's happening here ,, i see some news on this .. It has been a continuos decline in PPS since inception ,, What is the A/S and O/S ,, Have they any toxic debt ??
News out --- Chemesis International Inc. Signs Exclusive Offtake Agreement with HempRico
Press Release | 09/26/2019
VANCOUVER, British Columbia, Sept. 26, 2019 (GLOBE NEWSWIRE) -- Chemesis International Inc. (CSE: CSI) (OTC: CADMF) (FRA: CWAA) (the “Company” or “Chemesis”), is proud to announce its subsidiary, Natural Ventures, has signed an exclusive offtake agreement with HempRico LLC, (“HempRico”). HempRico has received a hemp cultivation license in Puerto Rico, and will begin planting an initial high-potency hemp crop in the coming weeks.
Natural Ventures is continuing to work with cultivators in Puerto Rico, by providing cultivators with direct access to high-quality manufacturing services. With the agreement with HempRico, the Company will manufacture high-potency CBD products for the medical market through finished goods such as tinctures, patches, edibles, and other high-CBD hemp-derived products. These products will be manufactured to a high standard to ensure compliance for distribution to international markets.
HempRico’s cultivation area is located in Cayey, a mountainous municipality that has a unique micro-climate for growing. The Company expects the elevation will provide consistently high-CBD crops that will be used to supply the medical market.
“Through this exclusive offtake agreement, Natural Ventures receives additional biomass and thus ensures our facilities receive a consistent supply of raw material from various sources,” said Chief Executive Officer, Edgar Montero. “Bolstering our production capability is a key element to ensure the Company is able to process the increasing amount of high-CBD crops. As Puerto Rico issues more licenses, Natural Ventures will work with cultivators and provide extraction and finished good manufacturing.”
On Behalf of The Board of Directors
Edgar Montero
CEO and Director
About Chemesis International Inc.
Chemesis International Inc. is a vertically integrated U.S. Multi-State operator with International operations in Puerto Rico and Colombia.
The Company focuses on prudent capital allocation to ensure it maintains a first mover advantage as it enters new markets and is committed to differentiate itself by deploying resources in markets with major opportunities. The Company operates a portfolio of brands that cater to a wide community of cannabis consumers, with focus on quality and consistency.
Chemesis has facilities in both Puerto Rico and California and is in the process of constructing a GMP certified facility in Colombia. Chemesis’ Puerto Rico operations are licensed to operate 100,000 ft2 of cultivation, and 35,000 ft2 of manufacturing floor space. The Company is positioned to win additional licenses in highly competitive merit-based US states and will expand its footprint to ensure it maintains a first mover advantage.
Investor Relations:
ir@chemesis.com
1 (604) 398-3378
Social Media:
Chemesis.facebook
Chemesis.twitter
Chemesis.instagram
DesertZen.instagram
GreenSpiritRX
Chemesis International Inc. Announces $6,000,000 USD Annual Minimum Purchase Order with PR ONE for Dry Flower & Cannabis Infused Goods
Chemesis’ subsidiary Natural Ventures signs an exclusive purchase order with PR ONE for a 3-year term
VANCOUVER, British Columbia, July 01, 2019 (GLOBE NEWSWIRE) -- Chemesis International Inc. (CSE: CSI) (OTC: CADMF) (FRA: CWAA) (the “Company” or “Chemesis”),through its subsidiary, Natural Ventures, announces it has signed an exclusive manufacturing agreement with PR ONE, a Puerto Rico based medical cannabis company. PR ONE’s flagship store is located in the San Juan Metro area and has over 6,000 ft2 of retail floor space. They are also currently working towards opening additional locations to meet growing demand from cannabis consumers.
The agreement has a 3-year term with automatic renewals and the initial orders will be for a minimum of $300,000 USD a month in cannabis infused products and a minimum of $200,000 USD in flower. Natural Ventures will be PR ONE’s main manufacturer and will maintain a first right of refusal for future products and additional dispensaries. As per the agreement, the initial order will be delivered in calendar Q4 of 2019 and as PR ONE’s demand increases, Natural Ventures will ensure it is able to meet PR ONE’s requirements.
“Natural Ventures continues to cement itself as a premier manufacturer for Puerto Rican cannabis companies and consumers,” said CEO of Chemesis, Edgar Montero. “Purchase orders from cannabis companies such as PR ONE serve as validation for our processes and continued dedication to quality and consistent products. Natural Ventures will continue to focus its efforts on securing more long-term contracts that build value and increase its presence in Puerto Rico.”
In addition, PR ONE will extend a line of credit of $500,000 USD at a 5% interest rate per annum. This line of credit will be extended to guarantee PR ONE's supply and will be used directly to ensure Natural Ventures meets purchase orders as they continue to grow
This is a great play for the long haul. one of a kind weed play
#CADMF: What do we have here...
That is some interesting history there, thanks for sharing.
Damn Smoke, your over here too? Must be a great stock to get into!
I read that too. Do you think it is for real?
Cheers FX
$CADMF The Warren Buffett Weed Play
One Company Is Following Warren's Formula and Investors Could Reap Berkshire Returns
By J. Daryl Thompson
The market is LOADED with opportunities for savvy investors to make a fortune in marijuana! And thanks to an increased push towards legalization in many states, there’s a LOT of untapped potential.
We’re seeing niches within the marijuana industry EXPLODE!
Companies are specializing from cultivation to distribution, to processing and manufacturing, and of course, to retail sales to consumers who are ‘patients’ and casual indulgers.
American exceptionalism is once again producing amazing companies!
However, most of those companies are too focused on one niche of the marijuana boom. They’re missing the Warren Buffett rule… and it could cost them millions.
But there’s ONE company who’s following Buffett's rule: Chemesis International (OTC:CADMF) (CSI:CSE)
Sponsored
Innovation from Seed To Sale Gives Investors MAJOR Upside
In the exploding Marijuana market, the ability to control costs from cultivation to retail sales has only upside. Where most companies in the marijuana industry lose profits is here… but Chemesis is the ONE company that can actually GROW profits!
See Where You Could Invest In Chemesis HERE
What Would Warren Do In Marijuana?
Warren Buffett’s approach is a simple one, and one that’s made him and his investors VERY rich.
Warren’s investing rule says “buy quality stocks at rock-bottom prices”. His real goal is to build more and more operating power for Berkshire Hathaway by owning stocks that will generate solid profits and capital appreciation for years to come.
The only one (at least that I know of) that is taking the Warren Buffett approach and hedging across multiple niches within an exploding sector is Chemesis (OTC:CADMF) (CSI:CSE). As a first-mover in the cannabis industry with worldwide reach, it operates in the most important and profitable sectors of the cannabis industry.
Chemesis is a company that is focused on acquiring growth potential companies within the Cultivation, Manufacturing, Delivery, AND Retail sectors. All of them reside under one conglomerate company, Chemesis International. They deliver strong management, global connections, experience in each niche, AND access to the coming flood of venture capital.
They are building brands and successful companies for more operating power, which makes for solid profit potential in the EXPLODING marijuana sector.
Warren would be proud!
A Marijuana Blue Chip Conglomerate
You see, Chemesis saw the opportunities in marijuana, but they also realized the RISK. So they did what Warren would do… hedge.
They researched 5 of the most profitable growth sectors of the industry, including cultivation, packaging, transportation, branding and retail, and acquired companies in these spaces who on their own were successful, but TOGETHER with a full leadership team looking at multiple aspects can bring massive profitability to each.
Chemesis International has a fully compliant state-of-the-art manufacturing facility that is 35,000 ft² and has a license to cultivate 100,000 ft² of cannabis. This rivals any in the market today. Chemesis currently has the capacity to produce 30,000+ lbs of cannabis per year and 90 kilos of crude oil per day. They also have multiple expansion opportunities in California, Columbia, and Puerto Rico.
Chemesis also owns Desert Zen, a manufacturing, transportation and distribution company, that has passed California’s stringent cannabis transportation laws. What’s more, they are able to track, monitor and ensure that all seed-to sale laws are followed throughout their business vertical. Desert Zen has even begun servicing other producers and brands throughout the region.
In August 2018, Chemesis International purchased an 80% interest in Natural Ventures, a seed-to-sale medicinal cannabis company in Puerto Rico, as well as SAP Global, an oil production facility in California. SAP Global is known for its high-quality oil-based products throughout the west coast. It has been the recipient of 26 awards in the past seven years.
Sponsored
Chemesis Scores Market Moving Brands
Chemesis controls or has exclusive partnerships with six high recognition brands with followings in the TENS OF MILLIONS on social media. When customers shop at ANY of the multi-state retails shops, they won’t miss one of the Chemesis brands, turning those purchases into investor profits!
Learn More About Chemesis Brands HERE
Recent Acquisitions and Buyouts
Chemesis announced last year that they have come into partnership with Rapid Dose Therapeutics (RDT), a Canadian bio-technology company providing disruptive proprietary drug delivery technologies designed to improve patient outcomes, with a novel proprietary therapeutic delivery system QuickStrip™ Oral Thin Strips to Puerto Rico and California.
At the end of the year, Chemesis International Inc. (OTC:CADMF) (CSI:CSE) made another acquisition and entered into a binding Letter of Intent to acquire 100% of Colombia-based La Finca Interacviva-Arachna Med SAS (La Finca), an integrated cannabis company licensed and operational in Colombia since 2017. La Finca has over 1,000 acres of outdoor cannabis cultivation and is aggressively exploring expansion opportunities throughout the country.
After securing the Puerto Rican and Colombian cannabis markets, CFN Media Group -- the leading agency and financial network of the North American cannabis industry -- published an article calling out the emerging Latin American market and specifically recognized Chemesis Latin America, Chemesis International’s new subsidiary, focusing on their disruption of Central and South American cannabis markets.
Along with their Latin American acquisition, Chemesis International has obtained a full line of CBD products, which are for sale in the U.S. Their Viverian line of CBD products are available for purchase in Arizona, Nevada, and Florida. The products are lab tested, THC free, and made of 100% botanical ingredients, all manufactured from a third party GMP certified facility.
Mainstream Weed Could Be Worth TRILLIONS
Even though North America has been stealing the spotlight the last few years, most of the fastest growing cannabis stocks are located to the North, in Canada where cannabis was recently legalized across the country. Cannabis is on pace to become a $10.8 billion industry by the end of 2019, with thousands of investors entering the market every day. Estimations for cannabis reach as high as $194 billion by 2026, and some believe has the potential to reach $1 trillion.
“Chemesis Latin America is a big step forward in our global growth strategy,” said CEO Edgar Montero
Sponsored
What Fully Compliant Distribution REALLY Means for Chemesis…
With the ability to cultivate over 30,000+lbs of product and manufacture 2,000 lbs of raw material into products and oils, Chemesis could supply the ENTIRE USA...but without the legal distribution, they’d be dead in the water. But they’ve partnered with a FULLY COMPLIANT distributor who can take their product into ANY state that can sell medicinal or recreational products produced by Chemesis.
It means the more states that get legal, they can INSTANTLY profit from product sales because they can LEGALLY deliver!
?Learn More About Chemesis's unique distribution process.
While Canada and the United States have stolen the media show, the opportunity in Latin America, which has been flying under the radar, is about to explode. Prohibition Partners believes that the Latin American cannabis industry will soon grow from $125 million in revenue this year to $12.7 billion by 2028. Many countries in South America like Puerto Rico and Columbia have legalized cannabis and struck exclusive production deals with select companies, like Chemesis International Inc. (OTC:CADMF) (CSI:CSE).
Now is the time to buy-in the ever-growing cannabis boom that is spreading like wildfire throughout not just our country, but nearly the entire western hemisphere. Many of the biggest opportunities lie just to the north, and now to the south, of our borders. Big money from hedge funds and blue-chip corporations like Constellation Brands, the producer of Corona and Modelo, as well as Coca-Cola, are striking deals with cannabis companies, giving immense overnight returns to investors. These same gigantic returns are about to hit companies like Chemesis, which have cornered their markets.
For example, Aphria went from a market cap of $313 million to $4.3 billion after firms Vanguard, Credit Suisse, RBC and BlackRock backed up their cash trucks and put their money down. The same happened to Aurora Cannabis, who went from a cap of $760 million, before Horizons Investment Management came in. Then followed investments from Goldman Sachs, Deutsche Bank, and UBS. Aurora’s stock skyrocketed, rising as high as 641% in a few weeks. Today, we’re witnessing a cannabis company with a market cap of $11.7 billion, an increase of 1,539%.
Given the explosive growth that Canadian companies have experienced in the 4th quarter of 2018 as they’ve gained huge investments from American companies and hedge funds, investors are getting nervous. With average valuations at 253 times earnings for the top four producers, it’s going to take a company that is willing to diversify and incorporate themselves into the U.S. market to hold on to their value. Certainly, all of the winners to date won’t, but more will, and they will require a different approach outside of heavily relying on cultivation, which is about to become a commodity-traded industry. That’s why the most recent cannabis stock fluctuations are caused by speculation that cannabis producers are diversifying into markets like beverages, dispensaries, distribution and branding.
The Chemesis International Inc. (OTC:CADMF)(CSI:CSE) model is based on diversification and following the Berkshire Hathaway model of streamlining companies into one business vertical. This allows them to profit at all levels of their own business-cycle and take profits from other cannabis companies with their own manufacturing, packaging and transportation arms to service other cannabis producers.
So why haven't many consumers heard of Chemesis?
Until recently, they’ve been focusing on growth! Berkshire wasn’t built in a day, and due to their unique business model, being positioned as a conglomerate in the industry like Procter & Gamble, Nestle or Berkshire Hathaway, it’s been head-down focused on growth. Chemesis has been buying out companies who are concentrated on the five most highly profitable and fastest growing cannabis sectors in the country.
And now, their model has come together to produce what could be an industry game-changer, and the first of its kind! This could produce huge rewards for their early investors.
I sold yesterday at $1.20, if that tells you where I’m at...
So think they hold their gains? Or do the insiders come around and steal your money again?
Let’s post links to all the Chemesis products for sale. Whether it’s jay and silent bob’s secret stash, California sap, natural ventures, or any others...
My contribution for today: Natural Ventures products on sale in a Puerto Rico dispensary.
https://prgreencross.com/product/natural-ventures-wedding-cake-oil-vape-500mg/
This stock jumps $.26 and not peep. C’mon y’all! Spread the word!
S/P jumped from $0.61 to $0.75 (23%) on 450 in volume. She’s thinnnn. Slap that ask boys! She likes it.
$$CADMF$$
FTMIG Interviews Edgar Montero, CEO of Chemesis! (CNSX: CSI) #CSI
https://www.ftmig.com/portfolio-view/ftmig-interviews-edgar-montero-ceo-of-chemesis-cnsx-csi/
Chemesis is uplisting to OTCQB. This is great news!
https://www.nasdaq.com/press-release/chemesis-international-inc-announces-approval-of-otcqb-uplisting-20181212-00816
INTERVIEW TODAY with Edgar Montero, CEO of Chemesis International! #CSI
LIVE STREAM:
https://www.facebook.com/Followthemoneyinvestorgroup/videos/1936820719767218/
Chemesis is about to pop. Checkout the chart’s 1 day resolution. The 12 day MA is juuuuuust about to cross above the 26.
$$CADMF$$ $$CSI$$
No one cares about Cheech. However, Tommy Chong seems to understand the industry pretty well. He has his own line of Chong’s Choice products and his own company. Jay and Silent Bob know nothing about the cannabis business, and neither does Chemesis.
However, remember when Chong went to prison for 9 months for illegally trafficking marijuana related products? His cell mate was the wolf of Wall Street, Jordan Belfort. That was cool.
I dunno Smoke. I’m pretty sure companies would love to have a licensing deal with Cheech and Chong. And if those two are not old washed-up stoners, I don’t know who is. You know what I mean?
Watch out for companies who use washed up celebrities to promote their business during start up phase...
Followers
|
21
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
149
|
Created
|
09/12/18
|
Type
|
Free
|
Moderators |
PER IHUB MGMT |
02-07-2021
DISCLAIMER: ONLY FOR MICK
https://investorshub.advfn.com/boards/profilea.aspx?user=1012
*The Board Monitor and herewithin , are not licensed brokers and assume NO responsibility for actions,
investments,decisions, or messages posted on this forum.
CONTENT ON THIS FORUM SHOULD NOT BE CONSIDERED ADVISORY NOR SOLICITATION
AUTHORS MAY HAVE BUYS OR SELLS WITH THE COMPANIES MENTIONED IN TRADING POSTERS SHOULD DUE DILIGENT BUYING OR SELLING.
ALL POSTING SHOULD BE CONSIDERED FOR INFORMATION ONLY. WE DO NOT RECOMMEND ANYONE BUY OR SELL ANY SECURITIES POSTED HEREWITHIN.
ANY trade entered into risks the possibility of losing the funds invested.
• There are no guarantees when buying or selling any security.Any
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |